Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-20

Clinical Trial Update: Tranexamic Acid Use and Blood Loss in Total Hip Arthroplasty

View source ↗

Summary

An Ohio State University study evaluated tranexamic acid use to reduce blood loss during total hip arthroplasty, and the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Ohio State University | Conditions: Tranexamic Acid Use, Blood Loss | Status: COMPLETED